Donanemab, Eli Lily's Revolutionary Alzhemier's Therapy

Medicine & Technology Mar 14, 2021

Eli Lily published detailed reports on the efficacy of Phase 2 clinical trials of donanemab, supporting the controversial amyloid hypothesis. Experts believe it could revolutionize Alzheimer's therapies.

Body Clock Strongly Associated With High Risk of Alzheimer’s Disease

Dec 21, 2020

Researchers discovered that YKL-40 is both controlled by clock genes and engaged in clearing away, possibly toxic accumulation of 'Alzheimer's proteins in the brain.'

Salmonella and Parkinson’s Share a Common Harmful Protein

Jul 10, 2020

Salmonella is found to infect the gut with the same protein that causes neurological disorders like Parkinson's as well as harmful autoimmunity.

Scientists Develop Vaccine Against Alzheimer's Disease

Jan 03, 2016

The vaccine targets the tangles found in the brains that can cause the memory loss.